Study of Melflufen (Melphalan Flufenamide) in Combination With Daratumumab in Relapsed-Refractory Multiple Myeloma
Clinical trial NCT04649060 · TERMINATED
Trial details
- NCT number
- NCT04649060
- Sponsor
- Oncopeptides AB
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-21
- Primary completion
- 2022-02-07
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.